Cross-talk between PKA and PKC in human fibroblasts: what are the pharmacotherapeutic implications?
- 31 August 2001
- journal article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 65 (3) , 275-279
- https://doi.org/10.1016/s0165-0327(00)00278-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Human fibroblasts as a relevant model to study signal transduction in affective disordersJournal of Affective Disorders, 2000
- 248. Protein kinase A in the postmortem brain of suicide victimsBiological Psychiatry, 2000
- Pharmacological actions of the antidepressant venlafaxine beyond aminergic receptorsInternational Journal of Neuropsychopharmacology, 1999
- Lack of β adrenoceptor desensitization in brain following the dual noradrenaline and serotonin reuptake inhibitor venlafaxineEuropean Neuropsychopharmacology, 1998
- Clinical efficacy of reboxetine: a comparative study with desipramine, with methodological considerationsHuman Psychopharmacology: Clinical and Experimental, 1998
- Rationale for the development of noradrenaline reuptake inhibitorsHuman Psychopharmacology: Clinical and Experimental, 1998
- Reduced [3H]Cyclic AMP Binding in Postmortem Brain from Subjects with Bipolar Affective DisorderJournal of Neurochemistry, 1997
- β-Adrenoceptor-Linked Protein Kinase A (PKA) Activity in Human Fibroblasts from Normal Subjects and from Patients with Major DepressionNeuropsychopharmacology, 1996
- The 5HT2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors.Proceedings of the National Academy of Sciences, 1990
- Distinct Adenosine 3′,5′-Monophosphate and Phorbol Ester-Responsive Signal Transduction Pathways Converge at the Level of Transcriptional Activation by the Interactions of DNA-Binding ProteinsMolecular Endocrinology, 1989